retatrutide low blood sugar New Kind of Diabetes Drug Helped People Lower and Lose Almost 40 Pounds New GLP-3 drug significantly slashes

This reassurance encourages clients to stay committed, knowing progress is both safe and effective

Abdominal distension or visible swelling Feeling uncomfortably full even after small meals Increased gas or flatulence Stomach discomfort or pressure Gurgling or rumbling sounds in the abdomen How common is bloating with GLP-1 treatments

This echoes the findings of a 2013 review, which found neither firm evidence in favor of this hypothesis nor evidence strong enough to rule out any such increased risk. Recent research also points to a link between the GLP-1 receptor agonist semaglutide and worsening diabetic retinopathy (DR)

What stands out about Yale Medicines approach to GLP-1 medications

Switching from Mounjaro to Wegovy or Wegovy to Mounjaro Mounjaro is a weight loss treatment, as well as a type 2 diabetes treatment, containing tirzepatide (a GLP-1 agonist)